{
  "id": "icd11#risk_safety_11b37201",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "Disorders due to substance use or addictive behaviours 463 Boundary with other mental disorders and other medical conditions Numerous mental disorders and subthreshold symptoms may co-occur with episodic or continuous patterns of substance use. Similarly, continuous or episodic substance use increases the risk of mental disorders and other medical conditions. Co-occurring mental disorders and comorbid medical conditions should be diagnosed separately, along with a diagnosis of harmful pattern of psychoactive substance use. Substance dependence Available categories by substance class 6C40.2 Alcohol dependence 6C41.2 Cannabis dependence 6C42.2 Synthetic cannabinoid dependence 6C43.2 Opioid dependence 6C44.2 Sedative, hypnotic or anxiolytic dependence 6C45.2 Cocaine dependence 6C46.2 Stimulant dependence, including amfetamines, methamfetamine and methcathinone 6C47.2 Synthetic cathinone dependence 6C49.2 Hallucinogen dependence 6C4A.2 Nicotine dependence 6C4B.2 Volatile inhalant dependence 6C4C.2 MDMA or related drug dependence, including MDA 6C4D.2 Dissociative drug dependence, including ketamine and PCP 6C4E.2 Other specified psychoactive substance dependence 6C4F.2 Multiple specified psychoactive substance dependence 6C4G.2 Unknown or unspecified psychoactive substance dependence Essential (required) features • A pattern of recurrent episodic or continuous use of a psychoactive substance is required for diagnosis, with evidence of impaired regulation of use of that substance that is manifested in two or more of the following: • impaired control over substance use (i.e. onset, frequency, intensity, duration, termination, context); • increasing precedence of substance use over other aspects of life, including maintenance of health, and daily activities and responsibilities, such that substance use continues or escalates despite the occurrence of harm or negative consequences (e.g. repeated relationship disruption, occupational or scholastic consequences, negative impact on health); • physiological features indicative of neuroadaptation to the substance, including tolerance to the effects of the substance or a need to use increasing amounts of the substance to achieve the same effect; withdrawal symptoms following cessation or reduction in use of that substance; or repeated use of the substance or Diagnostic requirements for disorders due to substance use |",
  "gloss_vi": "Disorders due to substance use or addictive behaviours 463 ranh giới with other mental disorders and other medical conditions numerous mental disorders and subthreshold symptoms may co-occur with episodic or continuous p...",
  "source": "WHO ICD-11",
  "url": "https://icd.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral"
    ],
    "life_topics": [
      "relationships"
    ],
    "advice_section": [
      "communication_tips"
    ],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn Disorders due to substance use or addictive behaviours 463 Boundary with other mental disorders and other medical conditions Numerous mental disorders and subthreshold symptoms may co-occur with episodic or continuous patterns of substance use. Similarly, continuous or episodic substance use increases the risk of mental disorders and other medical conditions. Co-occurring mental disorders and comorbid medical conditions should be diagnosed separately, along with a diagnosis of harmful pattern of psychoactive substance use. Substance dependence Available categories by substance class 6C40.2 Alcohol dependence 6C41.2 Cannabis dependence 6C42.2 Synthetic cannabinoid dependence 6C43.2 Opioid dependence 6C44.2 Sedative, hypnotic or anxiolytic dependence 6C45.2 Cocaine dependence 6C46.2 Stimulant dependence, including amfetamines, methamfetamine and methcathinone 6C47.2 Synthetic cathinone dependence 6C49.2 Hallucinogen dependence 6C4A.2 Nicotine dependence 6C4B.2 Volatile inhalant dependence 6C4C.2 MDMA or related drug dependence, including MDA 6C4D.2 Dissociative drug dependence, including ketamine and PCP 6C4E.2 Other specified psychoactive substance dependence 6C4F.2 Multiple specified psychoactive substance dependence 6C4G.2 Unknown or unspecified psychoactive substance dependence Essential (required) features • A pattern of recurrent episodic or continuous use of a psychoactive substance is required for diagnosis, with evidence of impaired regulation of use of that substance that is manifested in two or more of the following: • impaired control over substance use (i.e. onset, frequency, intensity, duration, termination, context); • increasing precedence of substance use over other aspects of life, including maintenance of health, and daily activities and responsibilities, such that substance use continues or escalates despite the occurrence of harm or negative consequences (e.g. repeated relationship disruption, occupational or scholastic consequences, negative impact on health); • physiological features indicative of neuroadaptation to the substance, including tolerance to the effects of the substance or a need to use increasing amounts of the substance to achieve the same effect; withdrawal symptoms following cessation or reduction in use of that substance; or repeated use of the substance or Diagnostic requirements for disorders due to substance use | Disorders due to substance use or addictive behaviours 463 ranh giới with other mental disorders and other medical conditions numerous mental disorders and subthreshold symptoms may co-occur with episodic or continuous p..."
}